IMARC Group, a leading market research company, has recently releases report titled “Drug Abuse Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”. The study provides a detailed analysis of the industry, including the global drug abuse testing market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the drug abuse testing market?
The global drug abuse testing market size reached US$ 6.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.9% during 2023-2028.
What is drug abuse testing?
Drug abuse refers to the deliberate consumption of illegal substances or the overconsumption of prescribed psychoactive and over-the-counter (OTC) medications. It can affect the mind and body and cause several disorders, including addiction. As a result, drug abuse is diagnosed by using numerous testing methods to treat related problems effectively. Drug abuse testing also aids in managing the mental status of a patient, handling seizure cases in the emergency room, identifying children and newborns at risk of exposure to illicit drugs, etc. It also finds extensive applications in workplaces where job applicants can be tested for drug usage before being hired.
Request for a sample copy of this report: https://www.imarcgroup.com/drug-abuse-testing-market/requestsample
What are the growth prospects and trends in the drug abuse testing industry?
The growing drug dependency and substance abuse among individuals for their mind-altering characteristics, medical, non-therapeutic and medicinal uses, and other purposes, such as weight loss, enhancing athletic performance, etc., are primarily driving the drug abuse testing market across the globe. In addition to this, the rising awareness about the harmful consequences of drug abuse, which can create prominent safety and health hazards and reduce the productivity and morale of an individual, is further propelling the product demand. Besides this, the escalating need for screening of employees and job applicants for providing a safe workplace and complying with stringent laws and regulations passed by government bodies is acting as another growth-inducing factor. Additionally, the improving technologies utilized by pain management and opioid dependency clinics are fueling the demand for urine drug testing, which is catalyzing the market growth. Moreover, the emergence of automated testing and analysis for drugs of abuse with at-home testing kits is projected to drive the global drug abuse testing market over the forecasted period.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product:
- Analyzers
- Immunoassays Analyzers
- Chromatographic Devices
- Breath Analyzers
- Rapid Testing Devices
- Urine Testing Devices
- Oral Fluid Testing Devices
- Consumables
- Laboratory Services
Breakup by Sample:
- Urine
- Oral Fluid (Saliva)
- Hair
- Breath
- Others
Breakup by End User:
- Hospitals
- Diagnostic Laboratories
- Forensic Laboratories
- Workplaces
- Others
Breakup by Region:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Abbott Laboratories
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Drägerwerk AG & Co. KGaA
- Hoffmann-La Roche AG
- Laboratory Corporation of America Holdings
- Omega Laboratories Inc.
- Quest Diagnostics Incorporated
- Siemens AG
- Thermo Fisher Scientific Inc.
- United States Drug Testing Laboratories Inc.
Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: [email protected]
Follow us on Twitter: @imarcglobal
About The Author
